Japan's mergers and acquisitions of Chinese companies in various fields have attracted attention
Japan's mergers and acquisitions of Chinese water plants, traditional Chinese medicine pharmaceutical companies, and Chinese salt companies, what does Japan want to do?
Some time ago, the Japanese in China "buy, buy, buy" move, attracted the attention of many people, unlike the previous Hong Kong developers in the mainland to buy land, Dongying's funds are more in China's water plants, traditional Chinese medicine enterprises and China's salt enterprises. In this world, the most important thing is income and returns, even local Chinese companies are not interested in Japanese investment in the country, some time ago, Japanese funds have been swelling wildly, so that many people have a variety of ideas.
Many netizens began to start from various conspiracies, accusing the Japanese of plotting wrong, and their merger and acquisition of traditional Chinese medicine and pharmaceutical companies is to rob the Chinese tradition, and they want to buy shares in water plants and salt enterprises, which is to monopolize the people's livelihood in our country. Although these words sound very reasonable, but if you think about it carefully, it is full of flaws, Chinese traditional Chinese medicine has a long history in China, and the Chinese medicine industry has long spread all over the country, how can the Japanese buy some pharmaceutical companies, how can it affect them?
And Dongying's money has entered our salt and water plants, and once Japan's funds really exceed the state's funds and control the water resources in certain areas, then **banks and localities** will definitely not allow this situation of "foreign entry and national retreat" to appear in their lives.
Therefore, some time ago, Japan's investment in Chinese people's life and traditional Chinese medicine was not as simple as everyone thought, and we did not always have a negative attitude, opposition or opposition. This is what Japan has invested in our country's turf, and if they have malicious intent and are not good for us, we can take action at any time and arrest them, and there will not be much risk.
Japanese funds have frequently taken action in our livelihood and health care industry.
Some time ago, although there were differences between China and Japan in the political and diplomatic fields, especially Japan's blatant dumping of nuclear wastewater into the Pacific Ocean, China and Japan quarreled even more. However, China and Japan have been "politically cold and economically hot" for a long time, and bilateral exchanges still maintain close ties.
Chinese companies such as Lenovo, BYD, and Xiaomi all have a lot of money in China, Masayoshi Son's SoftBank has injected capital into Alibaba, and Japanese companies such as Uniqlo and Muji have also begun to open branches in China. Prior to this, Dongying's funds were more in industries such as the Internet and cosmetics, but this is the first time that such a large-scale investment has been made in the medical industry.
As the saying goes, if there is no benefit, you will not stand up, and the reason why Japan's funds will be invested in domestic life and the pharmaceutical industry is also because of their long-term profitability, because funds are all chasing profits, and no one will use their love on the blade. At present, Japan's investment in China's residential water, traditional Chinese medicine and salt companies has accumulated as much as 10 billion US dollars, and its investment is so huge that it is really rare.
China is the world's largest freshwater protector with 2About 8 trillion cubic meters of fresh water, accounting for 6% of the world's total. Of course, there is still a long way to go between our country and Japan. After all, in China, there is no water like in Japan, as long as you turn on the faucet, you can drink it. Moreover, with people's higher and higher requirements for hygiene and cleanliness, drinking water and the drinking water industry have also become a huge cake in the eyes of the Dongying Foundation.
At the same time, in terms of traditional Chinese medicine health preservation, due to people's attention to health preservation, health preservation, health preservation, etc., the development space of China's traditional Chinese medicine industry continues to expand, and it is expected to exceed 150 billion US dollars in 2020. Taking salt as an example, China is the world's largest producer and user of salt, and people's daily life is closely related to salt.
All in all, Japan's large investment in China this time does not seem to be a high-yield, high-profit industry, but such as water plants, traditional Chinese medicine, etc., have stable income, and there will not be too much fluctuation, so their investment is very far-sighted.
The effect of Japanese companies' investment in China and its countermeasures.
In the current international environment, there is competition and cooperation between China and Japan, and Japan's M&A and investment in China's medical and health industry is undoubtedly a comprehensive demonstration of Japan's "soft power".
For a resource-poor country like Japan, as long as the basic strategic industries such as water conservancy, traditional Chinese medicine, and salt industry are controlled, it can not only effectively give back to the country, but also strengthen Japan's position and role in the global value chain, as well as Japan's voice in East Asia. As an excellent representative of Chinese tradition, traditional Chinese medicine enjoys a high reputation around the world. In this regard, once Japan's brand-name products are established, it will undoubtedly play a huge role in promoting the cultural connotation of Japanese companies and the expansion of the health care market.
At the same time, Japan's investment in traditional Chinese medicine will also promote exchanges and cooperation between the two countries in traditional Chinese medicine, promote mutual recognition of traditional Chinese medicine culture between the two countries, and promote the dissemination and dissemination of traditional Chinese medicine culture.
However, everything is good and bad, and the investment of Japanese companies in Japan's medical industry will undoubtedly cause an invisible impact on the Chinese people, and bring their products and national cultural values abroad, which is a potential cultural corrosion, which must arouse our vigilance and vigilance.
We have always been open-minded to all favorable foreign investment, especially in terms of people's livelihood, and the intervention of Japanese funds can effectively fill the social investment in some infrastructure projects, which greatly improves the quality of people's livelihood. Of course, we must also remain vigilant against these "private goods" and strangle them before they are formed.